Cargando…

Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic disease of unmet medical need. It is characterized by formation of scar tissue leading to a progressive and irreversible decline in lung function. IPF is associated with repeated injury, which may alter the composition of the extracellular matrix (ECM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radwanska, Agata, Cottage, Christopher Travis, Piras, Antonio, Overed-Sayer, Catherine, Sihlbom, Carina, Budida, Ramachandramouli, Wrench, Catherine, Connor, Jane, Monkley, Susan, Hazon, Petra, Schluter, Holger, Thomas, Matthew J., Hogaboam, Cory M., Murray, Lynne A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462497/ https://www.ncbi.nlm.nih.gov/pubmed/35993367 http://dx.doi.org/10.1172/jci.insight.153058

Ejemplares similares

Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF
por: Monkley, Susan, et al.
Publicado: (2021)

Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids
por: Ptasinski, Victoria, et al.
Publicado: (2023)

Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair
por: Prasad, Sony, et al.
Publicado: (2014)

Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesicles
por: Asghar, Sabha, et al.
Publicado: (2023)

Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death
por: Shah, Harshit, et al.
Publicado: (2023)

Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts
por: Schuliga, Michael, et al.
Publicado: (2018)

Are mast cells instrumental for fibrotic diseases?
por: Overed-Sayer, Catherine, et al.
Publicado: (2014)

Antibody-mediated depletion of CCR10(+)EphA3(+) cells ameliorates fibrosis in IPF
por: Hohmann, Miriam S., et al.
Publicado: (2021)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023)

Highlights of HRCT imaging in IPF
por: Sverzellati, N
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

The role of neutrophils in the pathogenesis of IPF
por: Jegal, Yangjin
Publicado: (2022)

Anti-Aging Effects of GDF11 on Skin
por: Rochette, Luc, et al.
Publicado: (2020)

A rare variant in the osteoarthritis-associated locus GDF5 is functional and reveals a site that can be manipulated to modulate GDF5 expression
por: Dodd, Andrew W, et al.
Publicado: (2013)

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior
por: Khine, Ngu, et al.
Publicado: (2020)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

The Role of Immunity and Inflammation in IPF Pathogenesis
por: Butler, Marcus W., et al.
Publicado: (2018)

Senescent Cells in IPF: Locked in Repair?
por: Meiners, Silke, et al.
Publicado: (2020)

IPF in Saudi Arabia: Lessons for all
por: Nathan, Steven D.
Publicado: (2020)

Microbiota and IPF: hidden and detected relationships
por: Fabbrizzi, Alessio, et al.
Publicado: (2021)

Radiological and Physiological Predictors of IPF Mortality
por: Kishaba, Tomoo, et al.
Publicado: (2021)

Moving senolytics closer to the clinic in IPF
por: Kramer, Daniel, et al.
Publicado: (2023)

Historical eye on IPF: a cohort study redefining the mortality scenario
por: Tomassetti, Sara, et al.
Publicado: (2023)

GDF15 and Cardiac Cells: Current Concepts and New Insights
por: Rochette, Luc, et al.
Publicado: (2021)

Structural basis for potency differences between GDF8 and GDF11
por: Walker, Ryan G., et al.
Publicado: (2017)

Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)

The Role of Cardiopulmonary Exercise Test in IPF Prognosis
por: Triantafillidou, Christina, et al.
Publicado: (2013)

Opioids: an unexplored option for treatment of dyspnea in IPF
por: Kohberg, Charlotte, et al.
Publicado: (2016)

Evolving Perspectives on Innate Immune Mechanisms of IPF
por: Ishikawa, Genta, et al.
Publicado: (2021)

IPF-Acute Exacerbations: Advances and Future Perspectives
por: Papiris, Spyros A., et al.
Publicado: (2022)

IPF Respiratory Symptoms Management — Current Evidence
por: Janowiak, Piotr, et al.
Publicado: (2022)

Epigenetic regulation of IPF fibroblast phenotype by glutaminolysis
por: Xiang, Zheyi, et al.
Publicado: (2022)

Histopathological evaluation of autopsy cases with isolated pulmonary fat embolism (IPFE): is cardiopulmonary resuscitation a main cause of death in IPFE?
por: Turkmen Samdanci, Emine, et al.
Publicado: (2019)

The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis
por: Stephenson, Katherine E., et al.
Publicado: (2023)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gv6u0c1r7eifiv644aktgqn7fv